Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads by Date

Must reads for theWeek ending April 22, 2018

Plerixafor did not affect 5-year survival in patients with NHL, Micallef I et al. Biol Blood Marrow Transplant (Published online 2 February 2018).https://doi.org/10.1016/j.bbmt.2018.01.039

Toxicities impact survival in NHL, Tallarico M et al. Journal of Geriatric Oncology (published online 17 April 2018) https://doi.org/10.1016/j.jgo.2018.03.018

Imaging guide to superficial soft tissue lymphomas, Lee et al, Clinical Imaging 2018 (49) 111-16. https://doi.org/10.1016/j.clinimag.2017.11.008

4 variants of DLBCL defined , Schmitz et al. New Eng J Med. 2018 Apr 11. doi: 10.1056/NEJMoa1801445

More must reads

Must reads for theWeek ending April 22, 2018

Plerixafor did not affect 5-year survival in patients with NHL, Micallef I et al. Biol Blood Marrow Transplant (Published online 2 February 2018).https://doi.org/10.1016/j.bbmt.2018.01.039

Toxicities impact survival in NHL, Tallarico M et al. Journal of Geriatric Oncology (published online 17 April 2018) https://doi.org/10.1016/j.jgo.2018.03.018

Imaging guide to superficial soft tissue lymphomas, Lee et al, Clinical Imaging 2018 (49) 111-16. https://doi.org/10.1016/j.clinimag.2017.11.008

4 variants of DLBCL defined , Schmitz et al. New Eng J Med. 2018 Apr 11. doi: 10.1056/NEJMoa1801445

More must reads

Must reads for theWeek ending April 15, 2018

Double hit, double expressor status doesn't affect response to allogeneic SCT, Herrera A et al. Biology of Blood and Marrow Transplantation 2018;24:514-20. https://doi.org/10.1016/j.bbmt.2017.11.023

New follicular lymphoma variant described, El Behery R et al. Human Pathology 72 2018 180-190 https://doi.org/10.1016/j.humpath.2017.11.002

More must reads

Must reads for theWeek ending April 8, 2018

Mantle cell lymphoma combo regimen gets 42% complete response rate, Tam C et al. N Engl J Med. 2018;378:1211-23.

Rare diffuse large B-cell lymphoma yields to lenalidomide, Beylot-Barry M et al. J Invest Dermatol. 2018 Mar 26. doi: 10.1016/j.jid.2018.03.1516

More must reads

Must reads for theWeek ending April 1, 2018

Follicular lymphoma responds to investigational PI3K inhibitor, Brown J et al. Lancet Haematol. 2018 Mar 14. doi: 10.1016/S2352-3026(18)30030-9.

Mantle cell response rate boosted by combo therapy, Tam C et al. N Engl J Med. 2018;378:1211-23.

Follicular lymphoma responded to mTOR inhibitor, Brown J et al. Lancet Haematol. 2018 Mar 14. doi: 10.1016/S2352-3026(18)30030-9.

More must reads

Pages